Boston, Medtronic invest in MIS (minimally invasive) valve firm:
This article was originally published in Clinica
Boston Scientific and Medtronic were among investors providing Fort Lee, New Jersey-based Percutaneous Valve Technologies with $14m. The two companies will each have a board representative at the company, which is developing a minimally invasive alternative to aortic valve replacement for aortic stenosis. Current treatment involves opening the chest, stopping the heart and placing the patient on a bypass machine. PVT is developing a device for placement under local anaesthesia in a cardiac catheterisation laboratory, which uses balloon-expandable stent technology and a bioprosthetic valve.